Glaukos, RadiusXR, and Topcon Healthcare Work to Advance Vision Testing

Topcon Healthcare Inc., RadiusXR, and Glaukos Corporation are teaming up to expand access to and help doctors provide visual field exams and glaucoma test education. The collaboration unites RadiusXR’s visual field platform and Topcon Healthcare’s expertise in robotic diagnostics and digital healthcare solutions with Glaukos’ mission to democratize ophthalmic disease diagnosis.

In addition, RadiusXR has launched a new wearable vision testing platform called Inspire. The company is marketing Inspire as the only commercially available wearable vision diagnostic system that combines visual field testing correlated to the clinical standard with proven performance, onboard patient education, and data-driven intelligence to support more informed clinical decisions. Six ounces and purpose-built for future expansion, Inspire extends beyond traditional diagnostics to support testing for other chronic and systemic conditions.

“The collaboration between RadiusXR, Topcon Healthcare, and Glaukos combines the experience and commitment of like-minded individuals with diagnostic and therapeutic solutions to accelerate the transformation of healthcare towards a more integrated, personalized approach for diagnosis and treatment,” Topcon Healthcare President/CEO Ali Tafreshi said. “By intelligently combining data from the new Inspire wearable vision testing platform with our robotic diagnostics on the Harmony digital health information platform, we are furthering our Healthcare from the Eye initiative with a truly dynamic digital healthcare ecosystem.”

The addition of the RadiusXR Inspire wearable visual field technology to Topcon Healthcare’s portfolio will streamline vision testing and make it more accessible for patients globally. Under this partnership, Topcon Healthcare will become the exclusive global distributor of the Inspire platform and will work with RadiusXR and Glaukos to expand the wearable diagnostic footprint through collaboration on commercialization efforts, research, and education. Additionally, Glaukos and Topcon Healthcare will work closely to advance patient engagement, education, and the digital eyecare ecosystem.

“We are pleased to partner with Topcon Healthcare to strengthen commercialization efforts for the RadiusXR technology and expand patient access to the Inspire platform,” Glaukos Chairman/CEO Thomas Burns stated. “This collaboration aligns with our mission to meaningfully advance the standard of care in glaucoma and improve outcomes by democratizing visual field testing and access to the digital tools needed to enable effective patient care worldwide.”

Inspire’s launch is a collaboration between RadiusXR, Topcon Healthcare, and Glaukos, leveraging each company’s expertise to accelerate advancement of vision diagnostics. By integrating wearable vision testing with comprehensive ophthalmic imaging and AI-driven data analysis, the three companies aim to expand access to high-quality eye care, enabling earlier disease detection, and driving smarter diagnostics.

“RadiusXR was founded with the mission of transforming digital health through innovation, and the launch of Inspire is a testament to that commitment,” RadiusXR CEO Ammad Khan commented. “By integrating our advanced wearable platform with Topcon Healthcare’s imaging solutions and Glaukos’ focus on patient engagement, we are delivering a truly connected and accessible diagnostic ecosystem that empowers clinicians and expands access to critical vision care.”

Topcon Healthcare Inc. is part of Topcon Corporation, a provider of digital healthcare solutions striving to improve healthcare access and quality while decreasing costs. To achieve this vision, the company created Healthcare from the Eye, a strategy of applying AI models to eye imaging data to facilitate earlier disease detection. Healthcare from the Eye is powered by Harmony, a cloud-based, vendor-inclusive digital health information platform enabling a connected care ecosystem.

RadiusXR is a digital healthcare technology company that solves complex healthcare issues. The firm is aiming to transform vision testing and eye care with an advanced digital platform that enables patient access, streamlines operations, and creates more confidence at the point of care. With its advanced wearable technologies, RadiusXR develops technologies that challenge the healthcare status quo.

Glaukos is an ophthalmic pharmaceutical and medical technology company developing and commercializing therapies to treat glaucoma, corneal disorders, and retinal diseases. Glaukos first developed Micro-Invasive Glaucoma Surgery (MIGS) as an alternative to the traditional glaucoma treatment paradigm, launching its first MIGS device commercially in 2012. In 2024, Glaukos initiated activities for iDose TR, a long-duration intracameral procedural pharmaceutical that delivers 24/7 glaucoma drug therapy inside the eye for extended periods of time. Glaukos also markets the only U.S. Food and Drug Administration-approved corneal cross-linking therapy using a proprietary bio-activated pharmaceutical to treat keratoconus. Glaukos continues to develop and advance dropless platform technologies that advance the standard of care and improve outcomes for patients suffering from chronic eye diseases.